02 May 2003
Competition and co-operation of PARP-1 and DNA-PK in the repair of DNA strand breaks
S. Veuger, N. Curtin, A. Calvert, D. Newell, R. Griffin, G. Smith, Z. Hostomsky, B. DurkaczMed Sci Monit 2003; 9(1): 74-0 :: ID: 15217
Abstract
Cells deficient in poly(ADP-ribose) polymerase (PARP-1) or DNA-dependent protein kinase (DNA-PK) are highly radiosensitive. Potent, specific inhibitors of PARP-1 (AG14361) and DNA-PK (NU7026) developed in collaboration with KuDOS Pharmaceuticals (UK) and Agouron/Pfizer GRD (CA), respectively, are radiosensitizers when used alone and in combination [1]. To fully exploit the potential of PARP-1 and DNA-PK inhibitors for cancer therapy, a mechanistic understanding of their interactions is essential. Reciprocal regulation by the two enzymes, and the effects of AG14361 and NU7026, were investigated using both purified enzyme assays and a permeabilised cell system. A 30 bp double stranded oligonucleotide was used to stimulate the activity of the enzymes. PARP-1 activity was not affected by the presence of DNA-PK, nor was DNA-PK activity affected by PARP-1 provided the substrates ATP and NAD were present. However, in the absence of ATP or the presence of NU7026, DNA-PK inhibited PARP-1 activity by 25% and 50% respectively. In the absence of NAD or the presence of AG14361, PARP-1 inhibited DNA-PK activity by 75%.Very similar results were obtained using the inhibitors in permeabilised cells either proficient or deficient in PARP-1 or DNA-PK. Ionizing radiation-induced DNA double strand break (DSB) repair in these cell lines was inhibited by both inhibitors and reduced DSB repair was also seen in the deficient cell lines. These data suggest that both PARP-1 and DNA-PK bind to DNA ends and co-operate in DSB repair. References: 1.Veuger SJ, Curtin NJ, Golding BT et al: Radiosensitisation and modulation of DNA repair by novel inhibitors of PARP and DNA-PK in vitro. Proc Am Assoc Cancer Res, 2002; 43: 4142
Keywords: PARP-1, DNA-PK, DNA Repair
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Review article
Comprehensive Insights into Arecoline Hydrobromide: Pharmacology, Toxicity, and PharmacokineticsMed Sci Monit In Press; DOI: 10.12659/MSM.945582
Clinical Research
Iliac Periosteal Bone Autografting vs Talus Non-Weight-Bearing Surgery in Hepple V Talus Osteochondral Inju...Med Sci Monit In Press; DOI: 10.12659/MSM.944912
Clinical Research
Impact of Different Orthodontic Appliances on Mandibular Condyle, Anterior Region of Mandibular, and Maxill...Med Sci Monit In Press; DOI: 10.12659/MSM.946265
Clinical Research
Risk Factors for Bone Cement Displacement After Percutaneous Kyphoplasty in Osteoporotic Vertebral Fracture...Med Sci Monit In Press; DOI: 10.12659/MSM.945884
Most Viewed Current Articles
17 Jan 2024 : Review article 6,371,831
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,909,013
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,468
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 260,595
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074